| Dorian Mann, NP | |
|
301 W Pine St, Blacksburg, SC 29702-1549 | |
| (864) 839-4325 | |
| Not Available |
| Full Name | Dorian Mann |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 301 W Pine St, Blacksburg, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821440215 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 20333 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Interim Healthcare Of The Upstate | Greenville, SC | Home health agency |
| Spartanburg Medical Center | Spartanburg, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spartanburg Medical Center | 3072425297 | 843 |
News Archive
NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.
TODAY, the Department of Agriculture's Center for Nutrition Policy and Promotion and the Department of Health and Human Services, will host an embargoed media conference call to discuss the release of the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010.
The Hill's Healthwatch blog reports that consumer groups and device makers are weighing in on a proposal to expedite the approval process for some medical devices.
Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
› Verified 1 days ago
| Entity Name | Spartanburg Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043309917 PECOS PAC ID: 3072425297 Enrollment ID: O20031105000129 |
News Archive
NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.
TODAY, the Department of Agriculture's Center for Nutrition Policy and Promotion and the Department of Health and Human Services, will host an embargoed media conference call to discuss the release of the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010.
The Hill's Healthwatch blog reports that consumer groups and device makers are weighing in on a proposal to expedite the approval process for some medical devices.
Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
› Verified 1 days ago
| Entity Name | Spartanburg Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699729939 PECOS PAC ID: 3072425297 Enrollment ID: O20040702000686 |
News Archive
NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.
TODAY, the Department of Agriculture's Center for Nutrition Policy and Promotion and the Department of Health and Human Services, will host an embargoed media conference call to discuss the release of the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010.
The Hill's Healthwatch blog reports that consumer groups and device makers are weighing in on a proposal to expedite the approval process for some medical devices.
Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
› Verified 1 days ago
| Entity Name | Woodruff Road Urgent Care Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598073496 PECOS PAC ID: 7911182084 Enrollment ID: O20110505000224 |
News Archive
NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.
TODAY, the Department of Agriculture's Center for Nutrition Policy and Promotion and the Department of Health and Human Services, will host an embargoed media conference call to discuss the release of the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010.
The Hill's Healthwatch blog reports that consumer groups and device makers are weighing in on a proposal to expedite the approval process for some medical devices.
Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
› Verified 1 days ago
| Entity Name | Bon Secours Ambulatory Services - St. Francis, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124495643 PECOS PAC ID: 0840590931 Enrollment ID: O20151120002171 |
News Archive
NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.
TODAY, the Department of Agriculture's Center for Nutrition Policy and Promotion and the Department of Health and Human Services, will host an embargoed media conference call to discuss the release of the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010.
The Hill's Healthwatch blog reports that consumer groups and device makers are weighing in on a proposal to expedite the approval process for some medical devices.
Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
› Verified 1 days ago
| Entity Name | Elite Patient Care Of South Carolina Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316477896 PECOS PAC ID: 1951672617 Enrollment ID: O20170731000866 |
News Archive
NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.
TODAY, the Department of Agriculture's Center for Nutrition Policy and Promotion and the Department of Health and Human Services, will host an embargoed media conference call to discuss the release of the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010.
The Hill's Healthwatch blog reports that consumer groups and device makers are weighing in on a proposal to expedite the approval process for some medical devices.
Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
› Verified 1 days ago
| Entity Name | Upstate Center For Addiction Treatment, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275249021 PECOS PAC ID: 6507229556 Enrollment ID: O20230824000851 |
News Archive
NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.
TODAY, the Department of Agriculture's Center for Nutrition Policy and Promotion and the Department of Health and Human Services, will host an embargoed media conference call to discuss the release of the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010.
The Hill's Healthwatch blog reports that consumer groups and device makers are weighing in on a proposal to expedite the approval process for some medical devices.
Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dorian Mann, NP 301 W Pine St, Blacksburg, SC 29702-1549 Ph: () - | Dorian Mann, NP 301 W Pine St, Blacksburg, SC 29702-1549 Ph: (864) 839-4325 |
News Archive
NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.
TODAY, the Department of Agriculture's Center for Nutrition Policy and Promotion and the Department of Health and Human Services, will host an embargoed media conference call to discuss the release of the Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010.
The Hill's Healthwatch blog reports that consumer groups and device makers are weighing in on a proposal to expedite the approval process for some medical devices.
Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
› Verified 1 days ago
Carol S Berry, F.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 301 W Pine St, Blacksburg, SC 29702 Phone: 864-839-4325 Fax: 803-839-9901 |